PK in patients with impaired renal function (Ep. 12)
Listen now
Description
In today’s episode I discuss the evaluation of pharmacokinetics in patients with impaired renal function. I include information from both the US FDA and EMA guidance documents linked below. I discuss the determination of when a dedicated renal impairment study is needed, characteristics of the study design and how to analyze and interpret the results.
Links discussed in the show:
• FDA guidance on PK in patients with impaired renal function
• EMA guidance on Evaluation of PK in patients with decreased renal function
• You can connect with me on LinkedIn and send me a message.
• Send me a message
• Sign up for my newsletter
Copyright Teuscher Solutions LLC
All Rights Reserved
More Episodes
Today’s show is about different work environments and not scientific topics. Throughout my career I have worked in many different types of companies, and I would like to share some observations with you from those experiences. I have held positions at startup companies or small biotechnology...
Published 05/27/24
Published 05/27/24
Today’s show discussed biosimilar development from a clinical pharmacology perspective. I describe what biosimilar products are and the necessary comparisons to the reference product. I review requirements for PK similarity, PD similarity, immunogenicity, and safety. I also touch on the idea of...
Published 05/13/24
Links
Twitter
Facebook
Instagram
Patreon
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
